Gregory Reaman

1.6k total citations
18 papers, 921 citations indexed

About

Gregory Reaman is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Pathology and Forensic Medicine. According to data from OpenAlex, Gregory Reaman has authored 18 papers receiving a total of 921 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Public Health, Environmental and Occupational Health, 6 papers in Pediatrics, Perinatology and Child Health and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Gregory Reaman's work include Acute Lymphoblastic Leukemia research (9 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Neuroblastoma Research and Treatments (4 papers). Gregory Reaman is often cited by papers focused on Acute Lymphoblastic Leukemia research (9 papers), Childhood Cancer Survivors' Quality of Life (5 papers) and Neuroblastoma Research and Treatments (4 papers). Gregory Reaman collaborates with scholars based in United States, Switzerland and Australia. Gregory Reaman's co-authors include Jean M. Tersak, Yutaka Yasui, Frederick B. Ruymann, Odile Oberlin, Elaine Morgan, Lisa Diller, Ravi Bhatia, Leslie L. Robison, Jillian M. Birch and Anna T. Meadows and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Gregory Reaman

18 papers receiving 886 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gregory Reaman United States 12 289 288 227 201 148 18 921
Jacques Otten Belgium 17 233 0.8× 456 1.6× 237 1.0× 260 1.3× 142 1.0× 35 989
Merlın Hamre United States 18 182 0.6× 209 0.7× 425 1.9× 212 1.1× 93 0.6× 29 1.1k
Clare J. Twist United States 14 272 0.9× 382 1.3× 270 1.2× 100 0.5× 97 0.7× 43 1.2k
J E Kingston United Kingdom 13 200 0.7× 208 0.7× 172 0.8× 135 0.7× 128 0.9× 27 806
Franca Fossati Bellani Italy 18 238 0.8× 242 0.8× 262 1.2× 245 1.2× 128 0.9× 40 1.1k
Violet Shen United States 17 277 1.0× 340 1.2× 273 1.2× 108 0.5× 250 1.7× 34 1.2k
Paolo Tamaro Italy 20 203 0.7× 239 0.8× 238 1.0× 225 1.1× 74 0.5× 57 1.1k
S. Sauter Germany 13 460 1.6× 691 2.4× 243 1.1× 242 1.2× 84 0.6× 20 1.1k
F Deméocq France 22 382 1.3× 424 1.5× 312 1.4× 234 1.2× 231 1.6× 78 1.5k
G Paolucci Italy 22 260 0.9× 352 1.2× 267 1.2× 205 1.0× 123 0.8× 90 1.3k

Countries citing papers authored by Gregory Reaman

Since Specialization
Citations

This map shows the geographic impact of Gregory Reaman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gregory Reaman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gregory Reaman more than expected).

Fields of papers citing papers by Gregory Reaman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gregory Reaman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gregory Reaman. The network helps show where Gregory Reaman may publish in the future.

Co-authorship network of co-authors of Gregory Reaman

This figure shows the co-authorship network connecting the top 25 collaborators of Gregory Reaman. A scholar is included among the top collaborators of Gregory Reaman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gregory Reaman. Gregory Reaman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Reaman, Gregory, Louis F. Stancato, Gilles Vassal, & John M. Maris. (2020). Crossing Oceans: Preclinical Collaboration to Improve Pediatric Drug Development. American Society of Clinical Oncology Educational Book. 40(40). 409–416. 2 indexed citations
2.
3.
Sadak, Karim Thomas, et al.. (2014). International patterns of childhood chronic myeloid leukemia: Comparisons between the United States and resource-restricted nations. Pediatric Blood & Cancer. 61(10). 1774–1778. 8 indexed citations
4.
Matloub, Yousif, Bruce Bostrom, Stephen P. Hunger, et al.. (2011). Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group. Blood. 118(2). 243–251. 94 indexed citations
5.
Meany, Holly J., Nita L. Seibel, Junfeng Sun, et al.. (2008). Phase 2 Trial of Recombinant Tumor Necrosis Factor-α in Combination With Dactinomycin in Children With Recurrent Wilms Tumor. Journal of Immunotherapy. 31(7). 679–683. 13 indexed citations
6.
7.
Kumar, Ambuj, Heloisa P. Soares, Robert J. Wells, et al.. (2005). Are experimental treatments for cancer in children superior to established treatments? Observational study of randomised controlled trials by the Children's Oncology Group. BMJ. 331(7528). 1295–1295. 54 indexed citations
8.
9.
Bhatia, Ravi, Yutaka Yasui, Leslie L. Robison, et al.. (2003). High Risk of Subsequent Neoplasms Continues With Extended Follow-Up of Childhood Hodgkin’s Disease: Report From the Late Effects Study Group. Journal of Clinical Oncology. 21(23). 4386–4394. 417 indexed citations
10.
Benjamin, Robert S., et al.. (2001). A phase I/II dose escalation and activity study of intravenous injections of OCaP1 for subjects with refractory osteosarcoma metastatic to lung.. PubMed. 12(12). 1591–3. 30 indexed citations
11.
Smith, Malcolm A., Howard D. Strickler, Gregory Reaman, et al.. (1999). Investigation of leukemia cells from children with common acute lymphoblastic leukemia for genomic sequences of the primate polyomaviruses JC virus, BK virus, and Simian virus 40. Medical and Pediatric Oncology. 33(5). 441–443. 20 indexed citations
12.
Uckun, Fatih M., Zhiwen Yang, Harland N. Sather, et al.. (1997). Cellular Expression of Antiapoptotic BCL-2 Oncoprotein in Newly Diagnosed Childhood Acute Lymphoblastic Leukemia: A Children's Cancer Group Study. Blood. 89(10). 3769–3777. 4 indexed citations
13.
Uckun, Fatih M., Paul S. Gaynon, Harland N. Sather, et al.. (1997). Clinical features and treatment outcome of children with biphenotypic CD2+ CD19+ acute lymphoblastic leukemia: a Children's Cancer Group study.. PubMed. 89(7). 2488–93. 15 indexed citations
14.
Packer, R. J., Joann L. Ater, Jeffrey C. Allen, et al.. (1997). Carboplatin and Vincristine Chemotherapy for Children with Newly Diagnosed Progressive Low-Grade Gliomas. Journal of Neuro-Ophthalmology. 17(4). 289–289. 1 indexed citations
15.
Packer, Roger J., Giorgio Perilongo, Leslie N. Sutton, et al.. (1992). Choroid plexus carcinoma of childhood. Cancer. 69(2). 580–585. 100 indexed citations
16.
Bulas, Dorothy, et al.. (1991). Pulmonary emboli as a primary manifestation of Wilms tumor.. American Journal of Roentgenology. 156(1). 155–156. 15 indexed citations
17.
Rosolen, A, Mahito Nakanishi, DG Poplack, et al.. (1989). Expression of interleukin-2 receptor beta subunit in hematopoietic malignancies. Blood. 73(7). 1968–1972. 65 indexed citations
18.
Rosolen, A, Mahito Nakanishi, DG Poplack, et al.. (1989). Expression of interleukin-2 receptor beta subunit in hematopoietic malignancies. Blood. 73(7). 1968–1972. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jacques Otten Breakdown of academic impact, for papers by Merlın Hamre Breakdown of academic impact, for papers by Clare J. Twist Breakdown of academic impact, for papers by J E Kingston Breakdown of academic impact, for papers by Franca Fossati Bellani Breakdown of academic impact, for papers by Violet Shen Breakdown of academic impact, for papers by Paolo Tamaro Breakdown of academic impact, for papers by S. Sauter Breakdown of academic impact, for papers by F Deméocq Breakdown of academic impact, for papers by G Paolucci
Rankless by CCL
2026